Consumo de medicamentos não padronizados na saúde indígena: uso racional?

Abstract

This article aimed to analyze the consumption of non-standard drugs in indigenous health, with emphasis on the rationality of pharmacotherapy. A cross-sectional study was conducted, based on secondary data, from the years 2018 and 2019 in the Special Sanitary District of Indigenous Health (DSEI-MG/ES). Non-standard drugs were classified according to the Anatomical Therapeutic Chemical Classification - ATC. Non-parametric tests were used to compare the origin of prescription and the form of acquisition, assessing access to medicines. Rationality was verified through the consumption profile and the therapeutic option in the list of standardized drugs. A total of 1,644 non-standard medications were consumed in the two years, corresponding to 104,928 capsules, tablets, and vials of medications. According to the ATC, 66,967 (66%) belonged to the alimentary tract and metabolism; 17,705 (17%) to the cardiovascular system; 12,961 (12%) to the nervous system. Among the most consumed drugs by the regions, 171 (90%) of the 190 non-standard drugs, had a therapeutic option. The prescriptions were significantly more from the SUS (p <0.001). Significant differences were found in the way the medications were acquired (p > 0.001). The study pointed out a highconsumption of non-standardized drugs, and there may be gaps in therapeutic rationality. In indigenous health, ethnocultural and social issues, such as the medicalization of health, constitute challenges for the access to medicines with rational use, as an attribute of citizenship.